.

Idera Pharmaceuticals reported $53K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agenus AGEN:US $ 2.83M 0.16M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Cytrx CYTR:US 43.48K 4.7K
Dynavax Technologies DVAX:US $ 0.13M 0M
Eli Lilly And LLY:US $ 594.1M 0M
GlaxoSmithKline GSK:LN 134700M 0M
Idera Pharmaceuticals IDRA:US $ 0.05M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M